Full Author : ['Gerstein, Hertzel C', 'Colhoun, Helen M', 'Dagenais, Gilles R', 'Diaz, Rafael', 'Lakshmanan, Mark', 'Pais, Prem', 'Probstfield, Jeffrey', 'Riesmeyer, Jeffrey S', 'Riddle, Matthew C', 'Ryden, Lars', 'Xavier, Denis', 'Atisso, Charles Messan', 'Dyal, Leanne', 'Hall, Stephanie', 'Rao-Melacini, Purnima', 'Wong, Gloria', 'Avezum, Alvaro', 'Basile, Jan', 'Chung, Namsik', 'Conget, Ignacio', 'Cushman, William C', 'Franek, Edward', 'Hancu, Nicolae', 'Hanefeld, Markolf', 'Holt, Shaun', 'Jansky, Petr', 'Keltai, Matyas', 'Lanas, Fernando', 'Leiter, Lawrence A', 'Lopez-Jaramillo, Patricio', 'Cardona Munoz, Ernesto German', 'Pirags, Valdis', 'Pogosova, Nana', 'Raubenheimer, Peter J', 'Shaw, Jonathan E', 'Sheu, Wayne H-H', 'Temelkova-Kurktschiev, Theodora']
Journal Title : Lancet (London, England)
Chapter : Section25, Section2, Section3, Section5, Section6
Journal Year : 2019
Cited by : 1866
BACKGROUND: Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high glycated haemoglobin A(1c) (HbA(1c)) concentrations. We assessed the effect o.....
Read More
